Last updated 2026-08-23
- Raised $36M B Round Extension led by Bosch Ventures, Apr 2024
- Raised $41.5M B Round Extension led by Peregrine Ventures, Feb 2022
- Raised $20M debt round led by Kreos Capital, Oct 2022
Total raised
$124.5M
Last: Undisclosed Round 2025-04
Stage
Series D
Founded
2014
Headcount
226
HQ
Tel Aviv-Yafo, Israel
Sector
HealthTech
About
Variantyx is an award-winning, technology-driven molecular diagnostics lab that offers innovative solutions in the genetic disorders, reproductive health, and precision oncology markets. Its proprietary whole genome analysis platform provides unparalleled diagnostic capabilities, enhances personalized treatment recommendations, shortens the time to diagnosis, and reduces healthcare costs.
The company offers a wide variety of test options, ranging from targeted to comprehensive analyses. Targeted analyses focus on pre-curated panels of indication-relevant genes while comprehensive analyses consider all genes. All tests are performed on a whole genome platform. This makes it easy to start with a targeted analysis and automatically reflex up to a comprehensive analysis if the first test is non-diagnostic. No additional sample or sequencing is required.
Funding history · 5 rounds · $124.5M total
5 events/rounds · $124.5M Total Funding: $104.5M in Private Equity, $20.0M in Debt
Apr 2024
Oct 2022
Feb 2022
Mar 2021
★ GHS Fund (Quark Venture LP and GF Securities)IBM VenturesPitango Venture Capital20/20 HealthCare Partners
Jun 2019
★ Pitango Venture Capital
Headcount over time
226 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Show all offices (1 more)
- Framingham, United States
Q&A
- What is Variantyx's primary focus?
- Variantyx is a technology-driven molecular diagnostics lab that provides advanced genomic diagnostic solutions in genetic disorders, reproductive health, and precision oncology markets.
- When was Variantyx founded?
- Variantyx was founded in May 2014.
- What is the total amount of funding Variantyx has raised to date?
- Variantyx has raised a total of $131.5 million USD.
- Which investors participated in Variantyx's funding round in April 2024?
- In April 2024, Variantyx received funding from Peregrine Ventures, Robert Bosch Venture Capital, Pitango HealthTech, and New Era Capital Partners.
- Which investor participated in Variantyx's funding round in October 2022?
- In October 2022, Variantyx received $20 million USD in funding from Kreos Capital.
- How many employees does Variantyx currently have?
- Variantyx has 201-500 employees.
- Who are the co-founders of Variantyx?
- The co-founders of Variantyx are Haim Neerman (Co-founder & CEO), Noam Shomron (Co-founder & CSO), and Tomer Jackman (Co-founder & VP Customer Support and Lab Services).
- Where is Variantyx's headquarters located?
- Variantyx's headquarters is located in Tel Aviv-Yafo, Israel.
- What is Variantyx's current funding stage?
- Variantyx is currently in its Series D funding stage.
Team · 24
Haim Neerman
Founder · CEO
Noam Shomron
Founder · Co-Founder
Tomer Jackman
Founder · VP Customer Support and Lab Services
Jeffrey Weisberg
Chief Financial Officer
Christine Stanley, PhD, FACMG
Chief Genomics and Compliance Officer
Eyal Reinstein, MD, PhD, DABMGG
Chief Medical Officer
Yaron Rachmany
COO
Tom DeLuca
Chief Human Resources Officer
Shirel Weiss, PhD
Vice President, Marketing
Elizabeth Garcia, PhD
Vice President, Lab Operations
Raya Neerman
Vice President of Sales Operations
Edward Sitar
CFO
Christopher Zerwas
VP Sales
David Margulies
Board Member
Hillel Bachrach
Board Member
Guy Ezekiel
Chairman
Zafrira Avnur
Board Member
Gideon Argov
Board Member
Eric Olivares
Chief Scientific Officer
Mark Jelley
Leadership
Benjamin Lund
Leadership
Karimah Es Sabar
Leadership
Lior Shahory, MBA
Leadership
Gadi Toren, MBA
Leadership
Sectors & technology
Primary sector
HealthTech
Technologies
Target customers
Business model
B2BB2C
Highlights
1 PatentsVerified
Tags
biopharmaceuticalpharma-companiespersonalizationprecision-medicineoncologynon-invasivepregnancypersonalized-medicinecancerclinical-datamedical-technologiesgenetic-disordershospitalsgenomicsdoctorsclinicslaboratoriesdiagnosticswomen-healthrare-diseasesdigital-healthcareartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | variantyx.com |
|---|---|
| linkedin.com/company/5378447 | |
| facebook.com/Variantyx |
Identifiers & details
| Legal name | VARIANTYX, INC. |
|---|---|
| Founded | 2014-5 |
| Employees (exact) | 226 |
| Offices | Framingham |
Radar intelligence
Publications (Crossref)
| Works | 10 |
|---|
GitHub
| Top repos | static |
|---|
Web history (Wayback)
| Domain | variantyx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 27 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515119709 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2014-08-07 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 5 — people (1), charge (4) |
| Registered address | גלגל הפלדה 11 הרצליה |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-30 | עדכון בעלי תפקידים |
| 2025-10-05 | רישום שעבוד |
| 2025-10-05 | רישום שעבוד |
| 2025-11-03 | סילוק שעבוד |
| 2025-11-03 | סילוק שעבוד |